Wed. 8 May 2024, 7:08am ET
Benzinga
Earnings, Earnings Misses, News
Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.21) by 42.86 percent. This is a 37.5 percent increase over losses of $(0.48) per share from the same period last year.